Top news of the week: 15.12.2020.
Healthcare
Sanofi suffers major setback in development of a Covid-19 vaccine
Sanofi had previously projected it could produce 100 million doses of vaccine in 2020, and 1 billion doses in 2021.
How Pfizer Delivered a Covid Vaccine in Record Time: Crazy Deadlines, a Pushy CEO
Pfizer CEO Albert Bourla and his team overcame unproven science and manufacturing bottlenecks to develop a Covid-19 vaccine in record time. But the effort put severe strain on the company’s ...
Exclusive: STAT News plans major expansion following banner year
"Covid didn't save us, but it helped propel us a lot faster."
Artificial Intelligence, Real Medicine
The value of safe and speedy medical innovation is clear.
The Week Ahead In Biotech: 2 IPOs Plus FDA Decisions On Moderna's COVID Vaccine And Drugs From Amgen, MacroGenics
Biotech stocks advanced for a third straight week, defying the broader market weakness. The space got solid support from positive stock reactions to presentations made at...
A Swiss biotech firm developing a Covid treatment has seen its share price soar 38,000% this year
Swiss biotech firm Relief Therapeutics has seen its share price climb by nearly 38,000% so far this year, as it develops a drug focused on respiratory failure arising from severe Covid-19.
The Daily Biotech Pulse: ASH Presentations, Axsome's Positive Midstage Readout, Follow-On Offerings
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Dec. 7) Affimed NV (NASDAQ: AFMD) (...
Bharat Biotech, Serum Institute of India Vaccines 'Not Considered' for Emergency Use Authorisation Over Lack of Data
Serum Institute of India (SII) and Bharat Biotech’s Covid-19 vaccines were "not considered" for emergency use authorization on Wednesday over lack of data, sources told News18 on Wednesday, ...